These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17171687)

  • 41. [Relationship between B-type natriuretic peptide plasma level and left ventricular function in patients with chronic kidney disease on different type of treatment].
    Rasić S; Hadzovic-Dzuvo A; Rebić D; Dzemidzić J; Bilal F; Mataradzija A
    Acta Med Croatica; 2008; 62 Suppl 1():7-11. PubMed ID: 18578326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical status and B-type natriuretic peptide levels in patients with heart failure at hospital discharge.
    Oral I; Mistrík J; Náplava R
    Herz; 2007 Oct; 32(7):583-8. PubMed ID: 17972033
    [TBL] [Abstract][Full Text] [Related]  

  • 44. B-type natriuretic peptide is predictive of hospitalization in community-dwelling elderly without heart diseases.
    Shimizu Y; Nishinaga M; Takata J; Miyano I; Okumiya K; Matsubayashi K; Ozawa T; Yasuda N; Doi Y
    Geriatr Gerontol Int; 2009 Jun; 9(2):148-54. PubMed ID: 19740358
    [TBL] [Abstract][Full Text] [Related]  

  • 45. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients.
    Post F; Weilemann LS; Messow CM; Sinning C; Münzel T
    Crit Care Med; 2008 Nov; 36(11):3030-7. PubMed ID: 18824903
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discriminating between cardiac and pulmonary dysfunction in the general population with dyspnea by plasma pro-B-type natriuretic peptide.
    Mogelvang R; Goetze JP; Schnohr P; Lange P; Sogaard P; Rehfeld JF; Jensen JS
    J Am Coll Cardiol; 2007 Oct; 50(17):1694-701. PubMed ID: 17950153
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery.
    Goei D; Schouten O; Boersma E; Welten GM; Dunkelgrun M; Lindemans J; van Gestel YR; Hoeks SE; Bax JJ; Poldermans D
    Am J Cardiol; 2008 Jan; 101(1):122-6. PubMed ID: 18157978
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE
    Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The value of echocardiography versus cardiac troponin I levels in the early detection of anthracycline cardiotoxicity in childhood acute leukemia: prospective evaluation of a 7-year-long clinical follow-up.
    Oztarhan K; Guler S; Aktas B; Arslan M; Salcioglu Z; Aydogan G
    Pediatr Hematol Oncol; 2011 Aug; 28(5):380-94. PubMed ID: 21699467
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia.
    Lipshultz SE; Lipsitz SR; Sallan SE; Dalton VM; Mone SM; Gelber RD; Colan SD
    J Clin Oncol; 2005 Apr; 23(12):2629-36. PubMed ID: 15837978
    [TBL] [Abstract][Full Text] [Related]  

  • 51. B-type natriuretic peptide in low-flow, low-gradient aortic stenosis: relationship to hemodynamics and clinical outcome: results from the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study.
    Bergler-Klein J; Mundigler G; Pibarot P; Burwash IG; Dumesnil JG; Blais C; Fuchs C; Mohty D; Beanlands RS; Hachicha Z; Walter-Publig N; Rader F; Baumgartner H
    Circulation; 2007 Jun; 115(22):2848-55. PubMed ID: 17515464
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma brain natriuretic peptide: a biochemical marker of effective blood pressure management?
    Andreadis EA; Georgiopoulos DX; Tzavara CK; Katsanou PM; Fragouli EG; Mavrokefalou EM; Chatzis NA; Ifanti GK; Diamantopoulos EJ
    J Hypertens; 2009 Feb; 27(2):425-32. PubMed ID: 19155794
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biomarkers and early detection of late onset anthracycline-induced cardiotoxicity in children.
    Sherief LM; Kamal AG; Khalek EA; Kamal NM; Soliman AA; Esh AM
    Hematology; 2012 May; 17(3):151-6. PubMed ID: 22664114
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes in natriuretic peptides following passive containment surgery in heart failure patients with dilated cardiomyopathy.
    Bredin F; Liska J; Franco-Cereceda A
    Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):191-4. PubMed ID: 19008326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer.
    Hayakawa H; Komada Y; Hirayama M; Hori H; Ito M; Sakurai M
    Med Pediatr Oncol; 2001 Jul; 37(1):4-9. PubMed ID: 11466716
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
    Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
    Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
    Lam CS; Burnett JC; Costello-Boerrigter L; Rodeheffer RJ; Redfield MM
    J Am Coll Cardiol; 2007 Mar; 49(11):1193-202. PubMed ID: 17367664
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
    Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma concentrations of NT-pro-BNP and cardiac troponin-I in relation to doxorubicin-induced cardiomyopathy and cardiac function in childhood malignancy.
    Soker M; Kervancioglu M
    Saudi Med J; 2005 Aug; 26(8):1197-202. PubMed ID: 16127512
    [TBL] [Abstract][Full Text] [Related]  

  • 60. B-type natriuretic peptide in patients with systemic right ventricle.
    Koch AM; Zink S; Singer H
    Cardiology; 2008; 110(1):1-7. PubMed ID: 17934262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.